Neuronetics, Inc. (STIM): Entry into a Material Definitive Agreement
Neuronetics, Inc. (STIM) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. As previously disclosed, on July 25, 2024, Neuronetics, Inc. (the “Company”) entered into a Credit Agreement and Guaranty (as amended, the “Existing Credit Agreement”) with Perceptive Credit Holdings IV, LP (“Perceptive”), as
- Instrument
- Amendment No. 6 to Credit Agreement and Guaranty
- Amount
- $15,000,000
- Lender
- Perceptive Credit Holdings IV, LP
Facts are quoted from the filing text and checked against it.
How this was made
The 30-second read
Why it matters
First disclosure of covenant modifications; investors will reassess credit risk.
Market read
A modest corporate financing update that could affect short‑term price dynamics.
What to watch
Potential impact of covenant changes on future financing costs and credit rating.
Background
The amendment updates the existing credit facility originally signed in 2024.
Ticker impact
Neuronetics filed an 8‑K reporting Amendment No. 6 to its credit agreement, modifying revenue covenants and adding a $15 M optional prepayment clause.
likely slight pressure as investors assess covenant changes
The filing is the first public disclosure of the amendment; market will price in potential covenant strain and the $15 M prepayment option.
Market effects
May signal tighter credit conditions for small‑cap med‑tech firms.
Limited to U.S. listed biotech/med‑tech segment.
Low
Counterpoint
If the optional prepayment is exercised, cash inflow could boost the balance sheet and support the stock.
Key entities
- companyNeuronetics, Inc.
Medical device company filing the amendment.
- lenderPerceptive Credit Holdings IV, LP
Administrative agent and majority lender on the credit agreement.

